Amedisys Inc (AMED)

$98.25

+0.5

(+0.51%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $97.67
    $98.88
    $98.25
    downward going graph

    0.59%

    Downside

    Day's Volatility :1.22%

    Upside

    0.64%

    downward going graph
  • $89.55
    $98.46
    $98.25
    downward going graph

    8.85%

    Downside

    52 Weeks Volatility :9.05%

    Upside

    0.21%

    downward going graph

Returns

PeriodAmedisys IncSector (Health Care)Index (Russel 2000)
3 Months
6.49%
6.5%
0.0%
6 Months
3.01%
7.1%
0.0%
1 Year
8.8%
9.8%
0.0%
3 Years
-61.69%
14.2%
-20.2%

Highlights

Market Capitalization
3.2B
Book Value
$33.3
Earnings Per Share (EPS)
-0.64
PEG Ratio
1.35
Wall Street Target Price
97.78
Profit Margin
-0.92%
Operating Margin TTM
9.15%
Return On Assets TTM
6.26%
Return On Equity TTM
-1.87%
Revenue TTM
2.3B
Revenue Per Share TTM
69.0
Quarterly Revenue Growth YOY
2.7%
Gross Profit TTM
454.0M
EBITDA
226.5M
Diluted Eps TTM
-0.64
Quarterly Earnings Growth YOY
-0.43
EPS Estimate Current Year
4.6
EPS Estimate Next Year
4.98
EPS Estimate Current Quarter
1.02
EPS Estimate Next Quarter
1.25

Analyst Recommendation

Hold
    44%Buy
    50%Hold
    5%Sell
Based on 18 Wall street analysts offering stock ratings for Amedisys Inc(by analysts ranked 0 to 5 stars)
Based on 18 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
7
Hold
9
9
8
Sell
1
1
1

Analyst Forecast

What analysts predicted

Downside of 0.48%

Current $98.25
Target $97.78

Company Financials

FY18Y/Y Change
Revenue
1.7B
↑ 8.4%
Net Income
119.3M
↑ 293.87%
Net Profit Margin
7.18%
↑ 5.2%
FY19Y/Y Change
Revenue
2.0B
↑ 17.63%
Net Income
126.8M
↑ 6.27%
Net Profit Margin
6.49%
↓ 0.69%
FY20Y/Y Change
Revenue
2.1B
↑ 5.93%
Net Income
183.6M
↑ 44.76%
Net Profit Margin
8.86%
↑ 2.37%
FY21Y/Y Change
Revenue
2.2B
↑ 6.88%
Net Income
209.1M
↑ 13.87%
Net Profit Margin
9.44%
↑ 0.58%
FY22Y/Y Change
Revenue
2.2B
↑ 0.41%
Net Income
118.6M
↓ 43.27%
Net Profit Margin
5.34%
↓ 4.1%
FY23Y/Y Change
Revenue
2.2B
↑ 0.59%
Net Income
-9.7M
↓ 108.22%
Net Profit Margin
-0.44%
↓ 5.78%
Q4 FY22Q/Q Change
Revenue
562.1M
↑ 0.73%
Net Income
31.7M
↑ 23.69%
Net Profit Margin
5.64%
↑ 1.04%
Q1 FY23Q/Q Change
Revenue
556.4M
↓ 1.01%
Net Income
25.2M
↓ 20.4%
Net Profit Margin
4.54%
↓ 1.1%
Q2 FY23Q/Q Change
Revenue
553.0M
↓ 0.61%
Net Income
-80.3M
↓ 417.97%
Net Profit Margin
-14.52%
↓ 19.06%
Q3 FY23Q/Q Change
Revenue
556.2M
↑ 0.59%
Net Income
26.0M
↓ 132.34%
Net Profit Margin
4.67%
↑ 19.19%
Q4 FY23Q/Q Change
Revenue
570.8M
↑ 2.62%
Net Income
39.4M
↑ 51.68%
Net Profit Margin
6.9%
↑ 2.23%
Q1 FY24Q/Q Change
Revenue
571.4M
↑ 0.11%
Net Income
14.4M
↓ 63.43%
Net Profit Margin
2.52%
↓ 4.38%
FY18Y/Y Change
Total Assets
717.1M
↓ 11.85%
Total Liabilities
234.5M
↓ 21.06%
FY19Y/Y Change
Total Assets
1.3B
↑ 76.09%
Total Liabilities
621.2M
↑ 164.93%
FY20Y/Y Change
Total Assets
1.6B
↑ 24.11%
Total Liabilities
756.5M
↑ 21.77%
FY21Y/Y Change
Total Assets
1.9B
↑ 18.49%
Total Liabilities
880.6M
↑ 16.42%
FY22Y/Y Change
Total Assets
2.0B
↑ 6.42%
Total Liabilities
869.7M
↓ 1.25%
FY23Y/Y Change
Total Assets
2.1B
↑ 4.25%
Total Liabilities
940.4M
↑ 8.13%
Q4 FY22Q/Q Change
Total Assets
2.0B
↓ 0.3%
Total Liabilities
869.7M
↓ 4.7%
Q1 FY23Q/Q Change
Total Assets
1.9B
↓ 1.48%
Total Liabilities
813.6M
↓ 6.45%
Q2 FY23Q/Q Change
Total Assets
2.0B
↑ 1.82%
Total Liabilities
921.6M
↑ 13.28%
Q3 FY23Q/Q Change
Total Assets
2.0B
↑ 2.27%
Total Liabilities
933.9M
↑ 1.33%
Q4 FY23Q/Q Change
Total Assets
2.1B
↑ 1.62%
Total Liabilities
940.4M
↑ 0.69%
Q1 FY24Q/Q Change
Total Assets
2.1B
↑ 1.44%
Total Liabilities
947.2M
↑ 0.73%
FY18Y/Y Change
Operating Cash Flow
223.5M
↑ 111.37%
Investing Cash Flow
-22.2M
↓ 49.59%
Financing Cash Flow
-267.4M
↑ 4728.89%
FY19Y/Y Change
Operating Cash Flow
202.0M
↓ 9.61%
Investing Cash Flow
-352.9M
↑ 1490.36%
Financing Cash Flow
227.2M
↓ 184.96%
FY20Y/Y Change
Operating Cash Flow
289.0M
↑ 43.05%
Investing Cash Flow
-287.1M
↓ 18.65%
Financing Cash Flow
-15.0M
↓ 106.59%
FY21Y/Y Change
Operating Cash Flow
188.9M
↓ 34.63%
Investing Cash Flow
-281.6M
↓ 1.92%
Financing Cash Flow
55.1M
↓ 468.07%
FY22Y/Y Change
Operating Cash Flow
133.3M
↓ 29.44%
Investing Cash Flow
-94.5M
↓ 66.45%
Financing Cash Flow
-30.4M
↓ 155.21%
Q4 FY22Q/Q Change
Operating Cash Flow
40.9M
↓ 399.95%
Investing Cash Flow
-1.9M
↑ 80.64%
Financing Cash Flow
-16.3M
↑ 518.86%
Q1 FY23Q/Q Change
Operating Cash Flow
26.0M
↓ 36.5%
Investing Cash Flow
45.9M
↓ 2559.59%
Financing Cash Flow
-56.9M
↑ 248.08%
Q2 FY23Q/Q Change
Operating Cash Flow
60.8M
↑ 134.04%
Investing Cash Flow
-7.7M
↓ 116.88%
Financing Cash Flow
-11.0M
↓ 80.75%

Technicals Summary

Sell

Neutral

Buy

Amedisys Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Amedisys Inc
Amedisys Inc
6.25%
3.01%
8.8%
-61.69%
-28.04%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
6.75%
1.59%
-22.77%
-49.63%
-45.76%
Hca Holdings, Inc.
Hca Holdings, Inc.
3.62%
24.47%
25.02%
43.55%
143.2%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
10.35%
80.65%
95.1%
108.93%
580.33%
Universal Health Services Inc.
Universal Health Services Inc.
8.08%
30.09%
44.94%
32.59%
34.96%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
0.24%
32.97%
40.81%
19.01%
139.9%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Amedisys Inc
Amedisys Inc
1170.13
NA
1.35
4.6
-0.02
0.06
NA
33.3
Fresenius Medical Care Ag
Fresenius Medical Care Ag
22.58
22.58
0.39
1.5
0.05
0.03
0.03
47.4
Hca Holdings, Inc.
Hca Holdings, Inc.
16.16
16.16
1.44
21.86
0.74
0.11
0.01
-6.06
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
5.46
5.46
1.74
8.98
0.54
0.07
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
15.8
15.8
1.87
13.79
0.13
0.06
0.0
93.48
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
16.31
16.31
1.16
9.32
0.43
0.06
NA
10.56
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Amedisys Inc
Amedisys Inc
Hold
$3.2B
-28.04%
1170.13
-0.92%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$11.9B
-45.76%
22.58
2.48%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$90.1B
143.2%
16.16
8.4%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$14.6B
580.33%
5.46
12.54%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$12.4B
34.96%
15.8
5.57%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$12.6B
139.9%
16.31
6.61%

Insights on Amedisys Inc

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 552.96M → 571.41M (in $), with an average increase of 1.1% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 39.37M → 14.4M (in $), with an average decrease of 63.4% per quarter

  • Vs THC

    In the last 1 year, Tenet Healthcare Corp.  has given 95.1% return, outperforming this stock by 86.3%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 108.9% return, outperforming this stock by 170.6%

Institutional Holdings

  • Vanguard Group Inc

    9.49%

  • BlackRock Inc

    9.20%

  • Fidelity International Ltd

    4.00%

  • Eckert Corp

    3.89%

  • Millennium Management LLC

    3.69%

  • Westchester Capital Management LLC

    3.00%

Company Information

amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i

Organization
Amedisys Inc
Employees
18700
CEO
Mr. Scott G. Ginn
Industry
Health Services

Discover More

FAQs